{
    "Symbol": "SNY",
    "AssetType": "Common Stock",
    "Name": "Sanofi ADR",
    "Description": "Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.",
    "CIK": "1121404",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "46 AVENUE DE LA GRANDE ARMEE, PARIS, FRANCE",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "129488372000",
    "EBITDA": "11754000000",
    "PERatio": "28.38",
    "PEGRatio": "0.838",
    "BookValue": "58.1",
    "DividendPerShare": "3.76",
    "DividendYield": "0.0394",
    "EPS": "1.82",
    "RevenuePerShareTTM": "18.81",
    "ProfitMargin": "0.0895",
    "OperatingMarginTTM": "0.143",
    "ReturnOnAssetsTTM": "0.0416",
    "ReturnOnEquityTTM": "0.0582",
    "RevenueTTM": "47080002000",
    "GrossProfitTTM": "31697000000",
    "DilutedEPSTTM": "1.82",
    "QuarterlyEarningsGrowthYOY": "-0.228",
    "QuarterlyRevenueGrowthYOY": "0.075",
    "AnalystTargetPrice": "59.89",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "28.38",
    "ForwardPE": "11.14",
    "PriceToSalesRatioTTM": "2.524",
    "PriceToBookRatio": "1.444",
    "EVToRevenue": "2.711",
    "EVToEBITDA": "9.99",
    "Beta": "0.408",
    "52WeekHigh": "55.72",
    "52WeekLow": "42.63",
    "50DayMovingAverage": "49.5",
    "200DayMovingAverage": "48.62",
    "SharesOutstanding": "2506550000",
    "DividendDate": "2024-06-06",
    "ExDividendDate": "2024-05-09"
}